PSYC (PSYC) Common Stock: $0.00 Mil (As of Jun. 2017)


What is PSYC Common Stock?

PSYC PSYC -99.00% Common Stock is $0.00 Mil as of Jun. 2017.

PSYC's quarterly common stock increased from Sep. 2016 ($17.44 Mil) to Dec. 2016 ($17.56 Mil) but then declined from Dec. 2016 ($17.56 Mil) to Jun. 2017 ($0.00 Mil).

PSYC's annual common stock declined from Dec. 2013 ($0.12 Mil) to Dec. 2014 ($0.00 Mil) but then increased from Dec. 2014 ($0.00 Mil) to Dec. 2016 ($17.56 Mil).

PSYC Common Stock Historical Data

* Premium members only.

The historical data trend for PSYC's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PSYC Common Stock Chart

PSYC Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec16
Common Stock
0.00 0.00 0.12 0.00 17.56

PSYC Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Dec14 Mar15 Jun15 Sep15 Mar16 Jun16 Sep16 Dec16 Jun17
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.02 11.47 17.44 17.56 0.00

PSYC Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
PSYC (PSYC) has a Common Stock of $0.00 Mil as of Jun. 2017. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PSYC and its competitors.
Is PSYC's Common Stock too high?
PSYC's current Common Stock is $0.00 Mil.
How does PSYC's Common Stock compare to ARLO and TAQR?
PSYC's Common Stock of $0.00 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Media - Diversified company?
A good Common Stock depends on the Media - Diversified industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PSYC and its competitors. PSYC's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PSYC stock overvalued right now?
PSYC (PSYC) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PSYC (PSYC), the current Common Stock is $0.00 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PSYC Business Description

Address 2881 South Valley View Boulevard, Suite 9, Las Vegas, NV, USA, 89102
PSYC Corp is a media-focused company serving the expanding industry and community of medicinal psychedelics. Through its media platform, Psychedelic Spotlight, the company has positioned itself right at the very core. These platforms provide the Company with an opportunity to dominate the intersection of cannabis and psychedelics as a media leader. Along with its subsidiary, the group offers public relations and media-focused services to companies within the medicinal psychedelics industry and other niche industries that include cannabis, holistic health, mining and precious metals, and others.